Home › Carcinoma a cellule squamose della testa e del collo › North Carolina › Charlotte
Studi clinici su Carcinoma a cellule squamose della testa e del collo a Charlotte, NC
10 studi su Carcinoma a cellule squamose della testa e del collo cercano partecipanti presso sedi a Charlotte e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
In reclutamentoFase 1
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville · a 13 mi di distanza
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
In reclutamentoFase 3
- Atrium Health Levine Cancer Institute, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
In reclutamentoFase 1/2
- Carolina Biooncology Institute, Huntersville · a 13 mi di distanza
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
In reclutamentoFase 1
- Carolina BioOncology Institute /ID# 272380, Huntersville · a 13 mi di distanza
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
In reclutamentoFase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Atrium Health University City/LCI-University, Charlotte
- e altri 5
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Carolina BioOncology Institute, Huntersville · a 13 mi di distanza
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- Carolina BioOncology Institute /ID# 232597, Huntersville · a 13 mi di distanza
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Carolina BioOncology Institute, Huntersville · a 13 mi di distanza
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
In reclutamentoFase 1
- Dren Investigational Site, Huntersville · a 13 mi di distanza
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
In reclutamentoFase 1
- Levine Cancer Institute, Charlotte
Studi su Carcinoma a cellule squamose della testa e del collo in altre città
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- Nashville, TN39 studi
- New York City, NY39 studi
- St. Louis, MO28 studi
- Arlington, VA26 studi
- Chicago, IL26 studi
- Philadelphia, PA26 studi
- Atlanta, GA24 studi
- San Antonio, TX22 studi
- Pittsburgh, PA22 studi
Altri studi a Charlotte
- Cancro (tutti i tipi)27 studi
- Cancro al seno22 studi
- Mieloma multiplo21 studi
- Cancro del polmone non a piccole cellule19 studi
- Leucemia mieloide acuta16 studi
- Obesità16 studi
- Sovrappeso15 studi
- Cancro colorettale13 studi
- Cancro ovarico12 studi
- Insufficienza cardiaca11 studi
- Cancro metastatico11 studi
- BPCO9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.